* If the product has intellectual property rights, a license granted is must or contact us.
Introduction of 22467-07-8 :
Gymnemagenin is a triterpenoid isolated from G. sylvestre. Gymnemagenin is an agent for diabetes and obesity and also possesses antiviral properties. In Vivo: Gymnemagenin has a poor oral bioavailability (~ 14 %) in rats. Gymnemagenin has a short half-life and a high clearance in rats. Gymnemagenin metabolizes rapidly with a short apparent and intrinsic half-life (~ 7 min) and high intrinsic clearance.